Please login to the form below

Not currently logged in
Email:
Password:

Sanofi appoints general manager UK

Hugo Fry previously served as chief marketing officer at Sanofi Pasteur

Sanofi Hugo FrySanofi has appointed Hugo Fry as the new general manager of its UK and Ireland business.

Fry brings over two decades of commercial, strategic and management experience to the Guildford-based branch, most recently from Sanofi Pasteur where he had been vice president and chief marketing officer since January 2015.

Prior to this, Fry served as global project leader for Lixisenatide at Sanofi's diabetes unit, having moved from TMC Pharma where he served as vice president of medical.

He also brings medical leadership expertise from Boehringer Ingelheim, Linde, Pfizer and the University of Surrey's Clinical Research Centre.
Fry said: “I am honoured to be appointed as general manager for the UK.

“I am proud and motivated to lead our more than 1,800 UK colleagues, who continuously demonstrate their commitment to serving the people whose lives we touch.

“Our ambition in the UK is to be a partner in improving the nation's health. We are dedicated to leveraging the unique diversity of our portfolio and strength of our pipeline toempower people to live life to the fullest."

3rd February 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics